Key Takeaways Intelligent Bio Solutions expands U.S. forensic market reach through a partnership with SMARTOX. The deal boosts INBS's fingerprint drug screening use in courts, prisons, and rehab centers. Intelligent Bio Solutions eyes FDA clearance to enter clinical and workplace testing markets.Intelligent Bio Solutions (INBS) recently expanded its U.S. forensic market presence through a strategic partnership with SMARTOX, a Texas-based leader in drug and alcohol screening services. The company’s breakth ...

SMARTOX has deployed over 50 of INBS' Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone As adoption grows in the U.S. Forensic Use Only market, INBS continues to actively pursue FDA clearance for its opiate test system for codeine. This effort aims to enable expansion into broader U.S. markets this year, including workplace drug testing, using its innovative fingerprint sweat-based testing technology. "We have partnere ...